XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,511,951 | -10.2% | 951,755 | +1.3% | 0.53% | -13.2% |
| Q2 2023 | $36,186,498 | -12.8% | 939,909 | -18.9% | 0.61% | -18.6% |
| Q1 2023 | $41,480,395 | -11.9% | 1,158,994 | -2.9% | 0.75% | -18.2% |
| Q4 2022 | $47,072,086 | +1.1% | 1,193,814 | -7.4% | 0.92% | +6.5% |
| Q3 2022 | $46,541,000 | +37.0% | 1,289,233 | +15.5% | 0.86% | +27.4% |
| Q2 2022 | $33,962,000 | +76.1% | 1,116,436 | +77.0% | 0.68% | +145.1% |
| Q1 2022 | $19,281,000 | +18.3% | 630,729 | +20.9% | 0.28% | +23.1% |
| Q4 2021 | $16,295,000 | – | 521,640 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |